Læknablaðið

Árgangur

Læknablaðið - 15.09.1991, Blaðsíða 47

Læknablaðið - 15.09.1991, Blaðsíða 47
LÆKNABLAÐIÐ 283 induced thrombocytopenia: Confirmation of diagnosis with in vitro methods. Blood 1975: 45: 395-401. 54. Cines DB. Kaywin P. Bina M, Tomaski A, Schreiber AD. Heparin associated thrombocytopenia. N Eng J Med 1980; 303: 788-95. 55. Chong BH. Pitney WR, Castaldi PA. Heparin- induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet 1982; ii: 1246- 9. 56. Lynch DM, Howe SE. Heparin-associated thrombocylopenia: antibody binding specificity to platelet antigens. Blood 1985; 66: 1176-81. 57. Cines DB. Tomaski A, Tannenbaum S. Immune endothelial- cell injury in heparin-associated thrombocytopenia. N Engl J Med 1987; 316: 581-9. 58. Bell WR, Tomasulu PA, Alving BM, Duffy TP. Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. Ann Intem Med 1976; 85: 155-60. 59. Root RK. Ryan JL. Humoral immunity and complement. In: Mandell GL. Douglas RG, Bennett JE, eds. Infectious Diseases, 2nd ed. New York: John Wiley and Sons, Inc, 1985: 31-57. 60. Aster RH, George JN. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In: Williams WJ. Beutler E, Erslev AJ, Lichtman MA, eds. Hematology, 4th ed. New York: McGraw-Hill, 1990: 1370-98. 61. Kappa JR. Fisher CA, Berkowitz HD. Cottrell ED, Addonizio. Heparin-induced platelet activation in 16 surgical patients: Diagnosis and management. J Vasc Surg 1987; 5: 101-9. 62. Chong BH, Steele R, Chesterman CN. Heparin- induced thrombocytopenia: A study of platelet IgG Fc receptors. Blood 1990; 76: 451a (suppl I). 63. Bymes JJ, Moake JL. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome: Evolving concepts of pathogenesis and therapy. Clin Hematol 1986; 15: 413-43. 64. Makhoul RG, Greenberg CS, McCann RL. Heparin- associated thrombocytopenia and thrombosis: A serious clinical problem and potential solution. J Vasc Surg 1986; 4: 522-8. 65. Tannenbaum SH, Finko R, Cines DB. Antibody and immunecomplexes induce tissue factor production by human endothelial cells. J Immunol 1986; 137: 1532- 7. 66. Kelton JG, Sheridan D. Brain H, Powers PJ, Turpie AG, Carter CJ. Clinical usefulness of testing for a heparin dependent platelet aggregating factor in patients with suspected heparin associated thrombocytopenia. J Lab Clin Med 1984; 103; 606- 12. 67. Boshkov LK, Warkentin TE, Hayward C, Andrew M, Kelton JG. Heparin-induced thrombocytopenia and thrombosis: Clinical and laboratory studies. Blood 1990; 76; 447a (suppl 1). 68. Cole CW, Bormanis J. Ancrod: A practical altemative to heparin. J Vasc Surg 1988; 8: 59-63. 69. Markwardt F. Prospective clinical use of hirudin as ■án anticoagulant. Biomed Progr 1990; 2: 19-23. 70. Hull RD, Raskob GE, Rosenbloom D, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Eng J Med 1990; 322: 1260- 4. 71. Mohr DN, Ryu JH, Litin SC, Rosenow EC. Recent advances in the managcment of venous thromboembolism. Mayo Clin Proc 1988; 63: 281- 90. 72. Laster J, Elfrink R, Silver D. Reexposure to heparin of patients with heparin-associated antibodies. J Vasc Surg 1989; 9; 677-82. 73. Janson PA, Moake JL, Carpinito G. Aspirin prevents heparin-induced platelet aggregation in vivo. Br J Hematol 1983; 53: 166-8. 74. Sobel M, Adelman B, Greenfield LJ. Dextran 40 reduces heparin-mediated platelet aggregation. J Surg Res 1986: 40: 382-7. 75. Turpie AGG. Clinical studies: Evidence for intervention with specific antiplatelet drugs in arterial thromboembolism. Sem Thromb Hemostas 1988; 14; 41-9. 76. Fitzgerald GA. Drug therapy: Dipyridamole. N Eng J Med 1987; 316: 1247-57. 77. Jakubowski JA, Maraganore JM. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin. Blood 1990; 75: 399- 406. 78. Teasdale SJ, Lulys VJ, Mycyk T, Baird RJ, Glynn MF. Ancrod anticoagulation for cardiopulmonary bypass in heparin- induced thrombocytopenia and thrombosis. Ann Thorac Surg 1989; 48: 712-3. 79. Demers C, Ginsberg J, Brill-Edwards P, et al. Ancrod therapy for heparin- induced thrombocytopenia (HIT). Blood 1990; 76: 504a (suppl 1). 80. Frame JN. Mulvey KP, Phares JC, Anderson MJ. Correction of severe heparin associated thrombocytopenia with intravenous gammaglobulin. Ann Int Med 1989; 111: 946-7. 81. Nand S, Robinson JA. Plasmapheresis in the management of heparin-associated thrombocytopenia with thrombosis. Am J Hematol 1988; 28: 204-6. 82. Bouvier JL, Lefevre P, Villain Ph, et al. Treatment of serious heparin- induced thrombocytopenia by plasma exchange: Report on 4 cases. Thromb Res 1988; 51: 335-6 (letter). 83. Thorp D, Canty A, Whiting J, et al. Plasma exchange and hcparin-induced thrombocytopenia. Progr Clin Biol Res 1990; 337: 521-2. 84. Cohen JI, Cooper MR, Greenberg CS. Streptokinase therapy of pulmonary emboli with heparin-associated thrombocytopenia. Arch Intem Med 1985; 135: 1725- 6. 85. Fiessingcr JN, Aiach M, Roncato M, Debure C, Gaux JC. Critical ischemia during heparin-induced thrombocytopenia. Treatment by intra-arterial streptokinase. Thromb Res 1984; 33: 235-8. 86. Delagardelle C, Harf C, Dondelinger RF, et al. Traitemet par thrombolyse locale d’une thrombose arterielle massive par thrombopenie induite par l’heparine. Arc Mal Coeur 1990; 83: 113-5. 87. Marder VJ, Sherry S. Thrombolytic therapy: Current status. (First of two parts). N Engl J Med 1988; 318: 1512- 20. 88. Mardcr VJ, Sherry S. Thrombolytic therapy: Current status. (Second of two parts). N Engl J Med 1988; 318: 1585-95. 89. Francis CW, Marder VJ, Evarts CM, Yaukoolbodi S. Two- step warfarin therapy: prevention of postoperative venous thrombosis without excessive bleeding. JAMA 1983; 249: 374-8. 90. Olinger GN, Hussey CV, Olive JA, Malik MI. Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation. J Thorac Cardiovasc Surg 1984; 87: 673-7. 91. Matsuo T, Yamada T, Chikahira Y, Kadowaki S. Effect of aspirin on heparin induced
Blaðsíða 1
Blaðsíða 2
Blaðsíða 3
Blaðsíða 4
Blaðsíða 5
Blaðsíða 6
Blaðsíða 7
Blaðsíða 8
Blaðsíða 9
Blaðsíða 10
Blaðsíða 11
Blaðsíða 12
Blaðsíða 13
Blaðsíða 14
Blaðsíða 15
Blaðsíða 16
Blaðsíða 17
Blaðsíða 18
Blaðsíða 19
Blaðsíða 20
Blaðsíða 21
Blaðsíða 22
Blaðsíða 23
Blaðsíða 24
Blaðsíða 25
Blaðsíða 26
Blaðsíða 27
Blaðsíða 28
Blaðsíða 29
Blaðsíða 30
Blaðsíða 31
Blaðsíða 32
Blaðsíða 33
Blaðsíða 34
Blaðsíða 35
Blaðsíða 36
Blaðsíða 37
Blaðsíða 38
Blaðsíða 39
Blaðsíða 40
Blaðsíða 41
Blaðsíða 42
Blaðsíða 43
Blaðsíða 44
Blaðsíða 45
Blaðsíða 46
Blaðsíða 47
Blaðsíða 48
Blaðsíða 49
Blaðsíða 50
Blaðsíða 51
Blaðsíða 52
Blaðsíða 53
Blaðsíða 54
Blaðsíða 55
Blaðsíða 56

x

Læknablaðið

Beinir tenglar

Ef þú vilt tengja á þennan titil, vinsamlegast notaðu þessa tengla:

Tengja á þennan titil: Læknablaðið
https://timarit.is/publication/986

Tengja á þetta tölublað:

Tengja á þessa síðu:

Tengja á þessa grein:

Vinsamlegast ekki tengja beint á myndir eða PDF skjöl á Tímarit.is þar sem slíkar slóðir geta breyst án fyrirvara. Notið slóðirnar hér fyrir ofan til að tengja á vefinn.